Kala Pharmaceuticals to Report First Quarter 2019 Financial Results and Host Conference Call
WATERTOWN, Mass.--(BUSINESS WIRE)--Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary AMPPLIFY™ mucus-penetrating particle (MPP) Drug Delivery Technology, today announced that it will report first quarter 2019 financial results on Thursday, May 9, 2019. Management will host a conference call and live audio webcast to discuss these results and provide a business update at 8:00 a.m. ET. The d